Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Wrone

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Journal of the American Academy of Dermatology|July 18, 2006
Sterility assessment of multiple use botulinum A exotoxin vials: a prospective simulationMurad Alam, Simon S Yoo, David A Wrone, et al.
Pathology, Research and Practice|December 25, 2002
Heparan sulphate proteoglycan in scleromyxedema promotes FGF-2 activityThomas F Warner, David A Wrone, Eliot C Williams, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Journal of the American Academy of Dermatology|July 18, 2006
Sterility assessment of multiple use botulinum A exotoxin vials: a prospective simulationMurad Alam, Simon S Yoo, David A Wrone, et al.
Pathology, Research and Practice|December 25, 2002
Heparan sulphate proteoglycan in scleromyxedema promotes FGF-2 activityThomas F Warner, David A Wrone, Eliot C Williams, et al.
Pageof 2